Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
about
Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV PathogenesisChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceHarnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosisHIV infection and older Americans: the public health perspectiveHIV infection, aging, and immune function: implications for cancer risk and preventionHIV: inflammation and boneTherapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTAlcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future DirectionsThoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United StatesMicrobial translocation and cardiometabolic risk factors in HIV infection.Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic ratsHuman Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryIs HIV a model of accelerated or accentuated aging?Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.Aging, human immunodeficiency virus, and bone health.Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapyHIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes.High IP-10 levels decrease T cell function in HIV-1-infected individuals on ARTStimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapyRetinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV infection: a novel estimator of vascular risk in HIV?Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.Corneal endothelial cells provide evidence of accelerated cellular senescence associated with HIV infection: a case-control study.Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trialAn internationally generalizable risk index for mortality after one year of antiretroviral therapy.Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.Retinal nerve fibre layer thickness and contrast sensitivity in HIV-infected individuals in South Africa: a case-control study.Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysisAssociation of Blood Biomarkers of Bone Turnover in HIV-1 Infected Individuals Receiving Anti-Retroviral Therapy (ART)Successful aging and the epidemiology of HIV.Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapyEffects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adultsBaseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals.HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD.
P2860
Q26747110-72552FAC-7D6F-4639-B49B-618386E4B5CEQ26825762-774B4F33-1202-4B02-81D1-A8F6B5D08DBBQ26828443-9622A815-4629-4F8B-98F5-A210D1E9F538Q26858824-A674396D-BF52-4292-AB1C-DE8D8BD759FDQ27004165-E7A6C09A-E371-4C9A-A226-DEF42B3D7484Q27010898-206EB334-EB45-474A-BDCC-3AA58646AED3Q28476094-79B2C2FB-5AC4-4458-8299-4284E688DF37Q30244921-C0F7167F-F90D-4096-A1DE-2C3E5783686FQ30364647-42F77357-12B9-4A93-8EC2-1806C5AFD6E2Q33590784-34D06849-8870-4E6E-B24B-33CEAA37C0B4Q33713895-9D44B47E-B5FA-4237-912C-788D026E5496Q33723186-0B7766A9-4156-4AC3-A06A-B6434C282800Q33742139-8C7096CA-7274-4C4E-B27E-55D5B5E83691Q33792651-2B112069-4854-4901-B9BC-4D63A1000672Q33863368-59D7DE94-8153-4488-8E38-F1A32F6166F6Q33924628-388F2C54-0C7E-4237-8145-E0A4D9180F53Q33963850-17DA2E98-522D-4A35-93D2-323B7A080324Q34068440-C7FB4E90-D2E6-49F2-B456-7AB55FAADD08Q34125560-E9C8E6DC-1C46-43D1-AB10-277D995196CEQ34153519-0F68ECA4-41DA-4772-8AB6-1B8E072C5F29Q34160511-2159AA48-A95D-4644-B5E5-181788DB57F4Q34328579-01C6278C-2927-40BE-8BC3-CE44CD8EDBBFQ34459345-85927121-C5F3-4D67-9976-0EE630E23531Q34484092-1307D4C0-C0EA-4002-AD53-47B049F6CD82Q34513996-391AF70F-0D0A-4035-A04A-7EC9EE44B53AQ34516572-C375B3B2-37A1-468A-A954-A4C080C33296Q34584634-8CECA5E6-3525-4B90-8CAA-93F224069BB2Q34608563-41DE6E12-5709-41C0-8BC3-C64CD6AD9B23Q34648954-C624F551-A7A7-4B56-9E1E-454608A6D74DQ34763977-A8FCB66D-ECC9-4B83-996B-58491BA6C511Q34813110-38B5F91A-1359-4FAB-8293-CFC68F9A38DAQ34943158-A29469D6-96BD-41EA-8C4A-10D7D520E8FDQ34998806-4C5F59FD-7993-427A-94DD-EAD7F9BF0BC5Q35036409-CC564F6D-C21D-461C-B0F2-F8155FBC7FFAQ35096244-726CD084-238E-4313-8B23-7630B3351A51Q35137873-CBF41A51-E350-4613-9F16-34BD8DB143E0Q35231863-9065A782-98BE-4A3C-8D79-C9A3024764D9Q35243077-3B308212-11E2-4327-9CDA-117078A817A3Q35356503-E004E2FB-AA7F-4CB6-89DF-40D2A04F33A6Q35575654-0E0C5C01-DB87-4695-968C-4038919EA82C
P2860
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Immune dysfunction, inflammati ...... nts on antiretroviral therapy.
@en
Immune dysfunction, inflammati ...... nts on antiretroviral therapy.
@nl
type
label
Immune dysfunction, inflammati ...... nts on antiretroviral therapy.
@en
Immune dysfunction, inflammati ...... nts on antiretroviral therapy.
@nl
prefLabel
Immune dysfunction, inflammati ...... nts on antiretroviral therapy.
@en
Immune dysfunction, inflammati ...... nts on antiretroviral therapy.
@nl
P1476
Immune dysfunction, inflammati ...... ents on antiretroviral therapy
@en
P2093
Steven G Deeks
P304
P577
2009-09-01T00:00:00Z